4//SEC Filing
BRYNJELSEN SEAN 4
Accession 0001493152-21-010524
CIK 0001710340other
Filed
May 4, 8:00 PM ET
Accepted
May 5, 4:16 PM ET
Size
5.3 KB
Accession
0001493152-21-010524
Insider Transaction Report
Form 4
BRYNJELSEN SEAN
DirectorPresident & CEO10% Owner
Transactions
- Award
Stock Option(Right to buy)
2021-05-03+245,000→ 1,185,000 totalExercise: $8.61Exp: 2031-05-03→ Common Stock (245,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest in 24 equal monthly installments from the date of grant until fully vested and exercisable on May 3, 2023.
Documents
Issuer
Eton Pharmaceuticals, Inc.
CIK 0001710340
Entity typeother
Related Parties
1- filerCIK 0001669976
Filing Metadata
- Form type
- 4
- Filed
- May 4, 8:00 PM ET
- Accepted
- May 5, 4:16 PM ET
- Size
- 5.3 KB